Royal Capital Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.83M | Hold |
3,634
| – | – | 1.88% | 12 |
|
|
2025
Q1 | $3M | Hold |
3,634
| – | – | 2.1% | 14 |
|
|
2024
Q4 | $2.81M | Buy |
3,634
+15
| +0.4% | +$11.6K | 1.97% | 14 |
|
|
2024
Q3 | $3.21M | Sell |
3,619
-250
| -6% | -$221K | 2.27% | 13 |
|
|
2024
Q2 | $3.5M | Buy |
3,869
+191
| +5% | +$173K | 2.64% | 11 |
|
|
2024
Q1 | $2.86M | Buy |
3,678
+484
| +15% | +$377K | 2.25% | 14 |
|
|
2023
Q4 | $1.86M | Hold |
3,194
| – | – | 1.61% | 17 |
|
|
2023
Q3 | $1.72M | Hold |
3,194
| – | – | 1.64% | 17 |
|
|
2023
Q2 | $1.5M | Buy |
3,194
+505
| +19% | +$237K | 1.41% | 21 |
|
|
2023
Q1 | $923K | Buy |
2,689
+100
| +4% | +$34.3K | 0.93% | 30 |
|
|
2022
Q4 | $947K | Buy |
2,589
+420
| +19% | +$154K | 1.01% | 29 |
|
|
2022
Q3 | $701K | Buy |
2,169
+360
| +20% | +$116K | 0.82% | 33 |
|
|
2022
Q2 | $587K | Buy |
1,809
+450
| +33% | +$146K | 0.64% | 37 |
|
|
2022
Q1 | $389K | Buy |
+1,359
| New | +$389K | 0.38% | 64 |
|